How Health Plans Can Keep Their Approach to New Markets Nimble, Collaborative, and Effective

Michael Flanagan
Michael Flanagan

Uncertainty regarding health insurance exchanges is not going away. Changing enrollment deadlines and newly insured populations have brought challenges to payers and providers. Success will require staying competitive on price, network quality, and access.

To succeed, a health plan needs new capabilities, such as flexible network management and an unprecedented level of coordination between payers and providers. Payers must be agile enough to adjust network strategies on the fly, as they learn more about newly enrolled populations. They need the ability to administer more complex product designs, care delivery. and reimbursement initiatives quickly and efficiently.

Unfortunately, current network operations often struggle because of multiple sources of provider data, disconnected reimbursement systems, and manual loading between network management and contract management. As the need for administrative savings grows and networks and reimbursement arrangements increase in number and complexity, the problem with existing systems will increase.

The road ahead requires preparation and challenges to current assumptions. Here is a template for health plans to drive their activity on the health insurance exchange:

Strategic Review

  • What progress has been made toward the company’s health insurance exchange goals?
  • Who are the customers? What providers will be needed to meet adequacy requirements? Is a narrow network needed?

Network Requirements

  • How will the company maintain and report on an adequate network?
  • How will it re-evaluate customer needs once enrollment for 2014 is clear?
  • What care management and customer engagement is required?

Contract Modeling

  • Will there be re-contracting?
  • How will the company manage providers and other partners that want to leave the arrangement?
  • What is the coverage arrangement in member-centric models where members have more flexibility in their provider choice?

Reimbursement Configuration

  • Risk models: how will the plan differentiate among and pay providers based on member, location, specialty, role, etc.?
  • How will the claims system(s) handle the variety of reimbursement models coherently?
  • Does the current system architecture support the company’s health insurance exchange needs?
  • Does the company have the flexibility and automation for long-term success?
  • What are the requirements on how to share information with members on costs before services are rendered, and what information can be shared? How will the health plan meet these requirements?

Fundamental to any exchange activity is staying nimble as marketplace complexity increases with the roll-out. Network, contract, and reimbursement operations must be able to respond to change quickly, while improving synchronization and automation to keep pace.

Michael Flanagan is associate vice president for product management at McKesson Health Solutions. He has more than 14 years of product management experience and works with the company’s network and claim management tools.

Managed Care’s Top Ten Articles of 2016

There’s a lot more going on in health care than mergers (Aetna-Humana, Anthem-Cigna) creating huge players. Hundreds of insurers operate in 50 different states. Self-insured employers, ACA public exchanges, Medicare Advantage, and Medicaid managed care plans crowd an increasingly complex market.

Major health care players are determined to make health information exchanges (HIEs) work. The push toward value-based payment alone almost guarantees that HIEs will be tweaked, poked, prodded, and overhauled until they deliver on their promise. The goal: straight talk from and among tech systems.

They bring a different mindset. They’re willing to work in teams and focus on the sort of evidence-based medicine that can guide health care’s transformation into a system based on value. One question: How well will this new generation of data-driven MDs deal with patients?

The surge of new MS treatments have been for the relapsing-remitting form of the disease. There’s hope for sufferers of a different form of MS. By homing in on CD20-positive B cells, ocrelizumab is able to knock them out and other aberrant B cells circulating in the bloodstream.

A flood of tests have insurers ramping up prior authorization and utilization review. Information overload is a problem. As doctors struggle to keep up, health plans need to get ahead of the development of the technology in order to successfully manage genetic testing appropriately.

Having the data is one thing. Knowing how to use it is another. Applying its computational power to the data, a company called RowdMap puts providers into high-, medium-, and low-value buckets compared with peers in their markets, using specific benchmarks to show why outliers differ from the norm.
Competition among manufacturers, industry consolidation, and capitalization on me-too drugs are cranking up generic and branded drug prices. This increase has compelled PBMs, health plan sponsors, and retail pharmacies to find novel ways to turn a profit, often at the expense of the consumer.
The development of recombinant DNA and other technologies has added a new dimension to care. These medications have revolutionized the treatment of rheumatoid arthritis and many of the other 80 or so autoimmune diseases. But they can be budget busters and have a tricky side effect profile.

Shelley Slade
Vogel, Slade & Goldstein

Hub programs have emerged as a profitable new line of business in the sales and distribution side of the pharmaceutical industry that has got more than its fair share of wheeling and dealing. But they spell trouble if they spark collusion, threaten patients, or waste federal dollars.

More companies are self-insuring—and it’s not just large employers that are striking out on their own. The percentage of employers who fully self-insure increased by 44% in 1999 to 63% in 2015. Self-insurance may give employers more control over benefit packages, and stop-loss protects them against uncapped liability.